First in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 17, 2022

Primary Completion Date

June 1, 2024

Study Completion Date

August 1, 2024

Conditions
Nonvalvular Atrial Fibrillation
Interventions
DEVICE

E-SeaLA, CardioPulse PFA system

First, pulmonary vein isolation(PVI) was performed with the novel hex spline PFA ablation catheter( CardioPulseTM PFA system, Hangzhou Dinova EP Technology Co., Ltd), then, pulsed field ablation and mechanical closure of the left atrial appendage were achieved by E-SeaLATM(Hangzhou Dinova EP Technology Co., Ltd) implantation.

Trial Locations (3)

110016

RECRUITING

General Hospital of Northern Theater Command, Shenyang

Unknown

RECRUITING

Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing

RECRUITING

Fuwai Central China Cardiovascular Hospital, Zhengzhou

All Listed Sponsors
lead

Hangzhou Dinova EP Technology Co., Ltd

INDUSTRY